Select Medical Q4 net income +63.9%, FY EPS $1.91; issues 2024 guidance

SELECT MEDICAL HOLDINGS CORP

2023-FY EPS reported $1.91 revenue$6,664,058,000

Q4 revenue $1,658.9M (+4.9% YoY); net income $61.8M (+63.9%); EPS $0.36 (+63.6%).
FY 2023 revenue $6,664.1M (+5.2%); net income $299.7M (+51.4%); adjusted EPS $1.99 (+61.8%).
Critical illness recovery hospital segment FY Adjusted EBITDA surged 121% to $246.0M.
Board declared $0.125/share dividend payable March 13, 2024; $1B stock buyback authorized through 2025.
2024 outlook: revenue $6.9B–$7.1B, Adjusted EBITDA $830M–$880M, EPS $1.88–$2.18.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SELECT MEDICAL HOLDINGS CORP reported fourth quarter ended December 31, 2023 results: revenue $1,658.9 million, net income $61.8 million, EPS $0.36.

Period: fourth quarter ended December 31, 2023
Revenue: $1,658.9 million
Net income: $61.8 million
EPS: $0.36
Result: reported results

Exact text from the filing

For the fourth quarter ended December 31, 2023, revenue increased 4.9% to $1,658.9 million, compared to $1,581.5 million for the same quarter, prior year.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SELECT MEDICAL HOLDINGS CORP reported year ended December 31, 2023 results: revenue $6,664.1 million, net income $299.7 million, EPS $1.91.

Period: year ended December 31, 2023
Revenue: $6,664.1 million
Net income: $299.7 million
EPS: $1.91
Result: reported results

Exact text from the filing

For the year ended December 31, 2023, revenue increased 5.2% to $6,664.1 million, compared to $6,333.5 million for the prior year.

View on SEC.gov

Browse all earnings releases →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-24-026568

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.